Effects of verapamil on [3H]norepinephrine release

Area of Science:

• Pharmacology
• Neuroscience
• Cardiovascular Science

Background:

• Calcium entry blockers are used for cardiovascular conditions.
• Their effects on norepinephrine release and baroreceptor reflexes are not fully understood.
• Investigating verapamil's impact on sympathetic neurotransmitter release is crucial.

Purpose of the Study:

• To determine if verapamil affects norepinephrine release from sympathetic nerves.
• To investigate the dose-dependent effects of verapamil on neurotransmitter release.
• To explore verapamil's influence on norepinephrine overflow in different vascular tissues.

Main Methods:

• Experiments utilized [3H]norepinephrine-incubated rat tail arteries and guinea pig vas deferens.
• Verapamil was superfused at varying concentrations (10(-9) M to 10(-4) M).
• Transmural electrical stimulation and spontaneous release were assessed, with and without cocaine or yohimbine pretreatment.

Main Results:

• Verapamil significantly increased [3H]norepinephrine overflow in rat arteries, with a ~400% increase at 10(-4) M.
• This effect was observed in Wistar Kyoto and spontaneously hypertensive rats, even after blocking neuronal uptake or alpha 2-adrenoceptors.
• Verapamil enhanced both stimulated and spontaneous [3H]norepinephrine release in guinea pig vas deferens in a dose-dependent manner.

Conclusions:

• Verapamil acts on sympathetic nerves to induce norepinephrine release.
• This action may contribute to the cardiovascular effects of verapamil.
• The findings highlight a potential interaction between calcium channel blockade and sympathetic neurotransmission.